pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Shift away from oppositional defiant disorder reflects changing views on child noncompliance

Sep 17, 2026·read at STAT ↗Neutral

Lawrence Diller, a behavioral pediatrician, writes about a noticeable shift in how clinicians label children who resist authority. He recounts a recent call from a mother who asked whether her son could be evaluated for PDA, a term she said stood for "pathological demand avoidance."\n\nDiller explains that PDA is being used to describe extreme non‑compliance, a label that has emerged as parents and professionals seek newer explanations for challenging behavior. The term contrasts with older diagnostic categories and reflects a broader trend toward re‑framing child conduct.\n\nAccording to Diller, the once‑common diagnosis of oppositional defiant disorder is fading from practice, suggesting that the field is moving away from that label in favor of newer concepts like PDA.

He argues that this disappearance signals a shift in how society and clinicians understand and respond to children who "won't listen."

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: What happened to oppositional defiant disorder?”

read at STAT ↗
2,332 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMICUS THERAPEUTICS, INC.3LEADING2CYCLE
topics
Psychiatry & CNS7Major Depression3Alzheimer's DiseaseCardiologyNeurologyOncologyRecall

related stories

  • 21h agoSionna says good-bye to 46% of staffers, including execBioSpace
  • Apr 28Opinion: Why do discussions about ‘brain health’ ignore mental illness?STAT
  • Aug 5Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-upfda medwatch
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jul 1412 ideas for tackling the U.S. alcohol epidemicSTAT